Letrozole: Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 November 2024

27 March 2024

26 March 2024

  • curprev 22:0622:06, 26 March 2024‎ Lazy talk contribs‎ 1,470 bytes −7‎ No edit summary
  • curprev 22:0522:05, 26 March 2024‎ Lazy talk contribs‎ 1,477 bytes +212‎ No edit summary
  • curprev 21:4921:49, 26 March 2024‎ Lazy talk contribs‎ 1,265 bytes +1,265‎ Created page with "{ "drug_name": "Letrozole", "FDA_approval": "Yes, for breast cancer; not FDA-approved for glioblastoma", "used_for": "Investigational use in glioblastoma based on preclinical studies", "clinical_trial_phase": "Preclinical studies and early research for glioblastoma", "common_side_effects": "Hot flashes, joint pain, nausea, fatigue, and risk of osteoporosis", "OS_with": "Not available; research in glioblastoma is still in early stages", "PFS_with": "Not avai..."
Retrieved from "http://glioblastomatreatments.wiki:80/index.php?title=Letrozole"